Michael M. Wick
2008
In 2008, Michael M. Wick earned a total compensation of $1.2M as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 52% increase compared to previous year.
Compensation breakdown
| Option Awards | $651,181 |
|---|---|
| Salary | $514,000 |
| Total | $1,165,181 |
Wick received $651.2K in option awards, accounting for 56% of the total pay in 2008.
Wick also received $514K in salary.
Rankings
In 2008, Michael M. Wick's compensation ranked 3,905th out of 9,135 executives tracked by ExecPay. In other words, Wick earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,905 out of 9,135 | 57th |
Division Manufacturing | 1,400 out of 3,436 | 59th |
Major group Chemicals And Allied Products | 264 out of 815 | 68th |
Industry group Drugs | 156 out of 597 | 74th |
Industry Pharmaceutical Preparations | 116 out of 408 | 72nd |
Source: SEC filing on April 7, 2010.
Wick's colleagues
We found four more compensation records of executives who worked with Michael M. Wick at MabVax Therapeutics Holdings in 2008.
2008
Cynthia Butitta
MabVax Therapeutics Holdings
Chief Financial Officer
2008
Stefan Ryser
MabVax Therapeutics Holdings
Former Senior Vice President, Corporate Strategy
2008
William Kaplan
MabVax Therapeutics Holdings
General Counsel
2008
Marc Steuer
MabVax Therapeutics Holdings